Navigation Links
Statement by Don Spence, CEO, Philips Home Healthcare Solutions, Endorsing CDC Educational Initiatives to Raise Awareness of Sleep Deprivation
Date:11/6/2009

MURRYSVILLE, Pa., Nov. 6 /PRNewswire/ -- Philips Respironics applauds the efforts of the Centers for Disease Control and Prevention (CDC) to raise awareness about an important public health issue -- chronic sleep insufficiency. The CDC's release of the first-ever government study to monitor state-by-state differences in sleeplessness is a milestone in quantifying the size and scope of the problem.

As a long-time educator, industry leader and sleep therapy manufacturer, Philips Respironics supports government efforts to draw attention to chronic sleep insufficiency, which remains under-reported and under-treated despite being associated with numerous physical and mental health problems, injury and mortality. It is estimated that 50 to 70 million Americans chronically suffer from a disorder of sleep and wakefulness, hindering daily functioning and adversely affecting their health and longevity.

Sleep - along with diet and exercise - is the third leg of the stool of good health. Nothing would have greater impact in reducing the health and safety toll of chronic sleep deprivation than the CDC's recommendation that healthcare providers consider adding an assessment of chronic rest or sleep insufficiency to routine office visits

Philips Respironics is dedicated to helping diagnose and improve the quality of life for Americans who experience sleep disorders. In 1985 we were the first company to commercialize continuous positive airway pressure (CPAP) therapy for treating Obstructive Sleep Apnea (OSA), a condition where a person's airway collapses repeatedly during sleep, preventing proper respiration and adequate rest. Today, CPAP therapy is the first-line of treatment for millions of OSA sufferers.

Sleep apnea is one of the world's most common sleep disorders, linked to a host of health problems including hypertension, insulin resistance, and increased risk of heart attack, stroke, and heart failure. We look forward to working with the government to educate Americans about sleep, sleep disorders, and the consequences of sleep deprivation.

SOURCE Philips Healthcare


'/>"/>
SOURCE Philips Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Amylin Pharmaceuticals and Eli Lilly and Company Statement on FDAs BYETTA(R) (Exenatide) Injection Update
2. PhRMA Statement Supporting Fair Incentives for Biologics Innovation
3. PhRMA Statement on Senate Finance Committee Vote
4. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
5. SCAI Statement on the BARI 2D Trial (Bypass Angioplasty Revascularization Investigation With Diabetes Trial) Presented at the American Diabetes Association (ADA) Annual Scientific Sessions and Published in The New England Journal of Medicine
6. EAU Position Statement on Screening for Prostate Cancer
7. Joint Statement from the American Diabetes Association and American Association of Clinical Endocrinologists on the NICE-SUGAR Study on Intensive Versus Conventional Glucose Control in Critically Ill Patients
8. A Joint Statement From Americas Prostate Cancer Advocacy, Education, and Support Organizations
9. Coalition for 21st Century Medicine Issues Statement in Opposition of Genentech Petition to Restrict Lab Use of Diagnostic Tests for Physicians and Patients
10. American Heart Association Scientific Statement: Heart Patients Should Be Screened, Treated for Depression
11. Deer Farm Industry in Michigan Issues Statement on the Negative CWD Test Results at Kent County Deer Farm
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... DUBLIN , April 20, 2017 ... "Latin America Pharmaceutical Contract Manufacturing Services Market Analysis By Service ... And Segment Forecasts, 2014 - 2025" report to their ... The Latin ... USD 21.0 billion by 2025 Low drug registration ...
(Date:4/19/2017)... NEW YORK , April 19, 2017 ... Surgical drainage devices are tubes used to remove excess ... include, blood, serum, pus, urine, bile or lymph. Surgical ... types of surgery such as orthopedics surgery, cardiovascular surgery, ... device is prophylactic post-surgery to prevent accumulation of fluid ...
(Date:4/19/2017)... Companion animal vaccines ... pets such as canine, avian and feline. ... such as Attenuated Live Vaccines, Conjugate Vaccines, Inactivated ... Recombinant Vaccines. Attenuated live vaccines are derived from ... have been weakend under laboratory conditions. Conjugate vaccines ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... ... Miami native and local periodontist Dr. John Paul Gallardo is celebrating ... 1991 that this journey would have taken me into so many learning experiences both ... has pioneered implant dentistry innovation, evolving into an internationally recognized leader in the industry. ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... today launched a unique website ( CRISPRCas.pioneer.com ) that demonstrates how this advanced ... farmers produce more and better food, with fewer resources. It highlights the business’ ...
(Date:4/26/2017)... Doylestown, Pa. (PRWEB) , ... ... ... Solutions division, which provides an agile ecosystem and domain expertise for sponsors ... end-to-end, configurable randomization and trial supply management (RTSM) software platform. Bioclinica ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a ... first in a new class of photodynamic cosmetics (PDC). , Allumera® is the ... reduce outward signs of aging, and minimize the appearance of pores – all ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... agreement to be the preferred physical therapy provider for Derby City CrossFit, effective ... Derby City CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists ...
Breaking Medicine News(10 mins):